Global 3D Printing Drug Formulation and Administration Market Research Report 2023

SKU ID :QYR-23527694 | Published Date: 14-Apr-2023 | No. of pages: 81
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global 3D Printing Drug Formulation and Administration Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 MED 1.2.3 FDM 1.2.4 SSE 1.2.5 Other 1.3 Market by Application 1.3.1 Global 3D Printing Drug Formulation and Administration Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Drugs 1.3.3 Dietary Supplement 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global 3D Printing Drug Formulation and Administration Market Perspective (2018-2029) 2.2 3D Printing Drug Formulation and Administration Growth Trends by Region 2.2.1 Global 3D Printing Drug Formulation and Administration Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 3D Printing Drug Formulation and Administration Historic Market Size by Region (2018-2023) 2.2.3 3D Printing Drug Formulation and Administration Forecasted Market Size by Region (2024-2029) 2.3 3D Printing Drug Formulation and Administration Market Dynamics 2.3.1 3D Printing Drug Formulation and Administration Industry Trends 2.3.2 3D Printing Drug Formulation and Administration Market Drivers 2.3.3 3D Printing Drug Formulation and Administration Market Challenges 2.3.4 3D Printing Drug Formulation and Administration Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top 3D Printing Drug Formulation and Administration Players by Revenue 3.1.1 Global Top 3D Printing Drug Formulation and Administration Players by Revenue (2018-2023) 3.1.2 Global 3D Printing Drug Formulation and Administration Revenue Market Share by Players (2018-2023) 3.2 Global 3D Printing Drug Formulation and Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by 3D Printing Drug Formulation and Administration Revenue 3.4 Global 3D Printing Drug Formulation and Administration Market Concentration Ratio 3.4.1 Global 3D Printing Drug Formulation and Administration Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by 3D Printing Drug Formulation and Administration Revenue in 2022 3.5 3D Printing Drug Formulation and Administration Key Players Head office and Area Served 3.6 Key Players 3D Printing Drug Formulation and Administration Product Solution and Service 3.7 Date of Enter into 3D Printing Drug Formulation and Administration Market 3.8 Mergers & Acquisitions, Expansion Plans 4 3D Printing Drug Formulation and Administration Breakdown Data by Type 4.1 Global 3D Printing Drug Formulation and Administration Historic Market Size by Type (2018-2023) 4.2 Global 3D Printing Drug Formulation and Administration Forecasted Market Size by Type (2024-2029) 5 3D Printing Drug Formulation and Administration Breakdown Data by Application 5.1 Global 3D Printing Drug Formulation and Administration Historic Market Size by Application (2018-2023) 5.2 Global 3D Printing Drug Formulation and Administration Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America 3D Printing Drug Formulation and Administration Market Size (2018-2029) 6.2 North America 3D Printing Drug Formulation and Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) 6.4 North America 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe 3D Printing Drug Formulation and Administration Market Size (2018-2029) 7.2 Europe 3D Printing Drug Formulation and Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) 7.4 Europe 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific 3D Printing Drug Formulation and Administration Market Size (2018-2029) 8.2 Asia-Pacific 3D Printing Drug Formulation and Administration Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific 3D Printing Drug Formulation and Administration Market Size by Region (2018-2023) 8.4 Asia-Pacific 3D Printing Drug Formulation and Administration Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America 3D Printing Drug Formulation and Administration Market Size (2018-2029) 9.2 Latin America 3D Printing Drug Formulation and Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) 9.4 Latin America 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa 3D Printing Drug Formulation and Administration Market Size (2018-2029) 10.2 Middle East & Africa 3D Printing Drug Formulation and Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) 10.4 Middle East & Africa 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Aprecia Pharmaceuticals 11.1.1 Aprecia Pharmaceuticals Company Detail 11.1.2 Aprecia Pharmaceuticals Business Overview 11.1.3 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Introduction 11.1.4 Aprecia Pharmaceuticals Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.1.5 Aprecia Pharmaceuticals Recent Development 11.2 Triastek 11.2.1 Triastek Company Detail 11.2.2 Triastek Business Overview 11.2.3 Triastek 3D Printing Drug Formulation and Administration Introduction 11.2.4 Triastek Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.2.5 Triastek Recent Development 11.3 FabRx 11.3.1 FabRx Company Detail 11.3.2 FabRx Business Overview 11.3.3 FabRx 3D Printing Drug Formulation and Administration Introduction 11.3.4 FabRx Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.3.5 FabRx Recent Development 11.4 Multiply Labs 11.4.1 Multiply Labs Company Detail 11.4.2 Multiply Labs Business Overview 11.4.3 Multiply Labs 3D Printing Drug Formulation and Administration Introduction 11.4.4 Multiply Labs Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.4.5 Multiply Labs Recent Development 11.5 Merck KgaA 11.5.1 Merck KgaA Company Detail 11.5.2 Merck KgaA Business Overview 11.5.3 Merck KgaA 3D Printing Drug Formulation and Administration Introduction 11.5.4 Merck KgaA Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.5.5 Merck KgaA Recent Development 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Company Detail 11.6.2 GlaxoSmithKline Business Overview 11.6.3 GlaxoSmithKline 3D Printing Drug Formulation and Administration Introduction 11.6.4 GlaxoSmithKline Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.6.5 GlaxoSmithKline Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Detail 11.7.2 Pfizer Business Overview 11.7.3 Pfizer 3D Printing Drug Formulation and Administration Introduction 11.7.4 Pfizer Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.7.5 Pfizer Recent Development 11.8 Craft Health 11.8.1 Craft Health Company Detail 11.8.2 Craft Health Business Overview 11.8.3 Craft Health 3D Printing Drug Formulation and Administration Introduction 11.8.4 Craft Health Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) 11.8.5 Craft Health Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global 3D Printing Drug Formulation and Administration Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of MED Table 3. Key Players of FDM Table 4. Key Players of SSE Table 5. Key Players of Other Table 6. Global 3D Printing Drug Formulation and Administration Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global 3D Printing Drug Formulation and Administration Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global 3D Printing Drug Formulation and Administration Market Size by Region (2018-2023) & (US$ Million) Table 9. Global 3D Printing Drug Formulation and Administration Market Share by Region (2018-2023) Table 10. Global 3D Printing Drug Formulation and Administration Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global 3D Printing Drug Formulation and Administration Market Share by Region (2024-2029) Table 12. 3D Printing Drug Formulation and Administration Market Trends Table 13. 3D Printing Drug Formulation and Administration Market Drivers Table 14. 3D Printing Drug Formulation and Administration Market Challenges Table 15. 3D Printing Drug Formulation and Administration Market Restraints Table 16. Global 3D Printing Drug Formulation and Administration Revenue by Players (2018-2023) & (US$ Million) Table 17. Global 3D Printing Drug Formulation and Administration Market Share by Players (2018-2023) Table 18. Global Top 3D Printing Drug Formulation and Administration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Drug Formulation and Administration as of 2022) Table 19. Ranking of Global Top 3D Printing Drug Formulation and Administration Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by 3D Printing Drug Formulation and Administration Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players 3D Printing Drug Formulation and Administration Product Solution and Service Table 23. Date of Enter into 3D Printing Drug Formulation and Administration Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global 3D Printing Drug Formulation and Administration Market Size by Type (2018-2023) & (US$ Million) Table 26. Global 3D Printing Drug Formulation and Administration Revenue Market Share by Type (2018-2023) Table 27. Global 3D Printing Drug Formulation and Administration Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global 3D Printing Drug Formulation and Administration Revenue Market Share by Type (2024-2029) Table 29. Global 3D Printing Drug Formulation and Administration Market Size by Application (2018-2023) & (US$ Million) Table 30. Global 3D Printing Drug Formulation and Administration Revenue Market Share by Application (2018-2023) Table 31. Global 3D Printing Drug Formulation and Administration Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global 3D Printing Drug Formulation and Administration Revenue Market Share by Application (2024-2029) Table 33. North America 3D Printing Drug Formulation and Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) & (US$ Million) Table 35. North America 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe 3D Printing Drug Formulation and Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific 3D Printing Drug Formulation and Administration Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific 3D Printing Drug Formulation and Administration Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific 3D Printing Drug Formulation and Administration Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America 3D Printing Drug Formulation and Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa 3D Printing Drug Formulation and Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa 3D Printing Drug Formulation and Administration Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa 3D Printing Drug Formulation and Administration Market Size by Country (2024-2029) & (US$ Million) Table 48. Aprecia Pharmaceuticals Company Detail Table 49. Aprecia Pharmaceuticals Business Overview Table 50. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product Table 51. Aprecia Pharmaceuticals Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 52. Aprecia Pharmaceuticals Recent Development Table 53. Triastek Company Detail Table 54. Triastek Business Overview Table 55. Triastek 3D Printing Drug Formulation and Administration Product Table 56. Triastek Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 57. Triastek Recent Development Table 58. FabRx Company Detail Table 59. FabRx Business Overview Table 60. FabRx 3D Printing Drug Formulation and Administration Product Table 61. FabRx Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 62. FabRx Recent Development Table 63. Multiply Labs Company Detail Table 64. Multiply Labs Business Overview Table 65. Multiply Labs 3D Printing Drug Formulation and Administration Product Table 66. Multiply Labs Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 67. Multiply Labs Recent Development Table 68. Merck KgaA Company Detail Table 69. Merck KgaA Business Overview Table 70. Merck KgaA 3D Printing Drug Formulation and Administration Product Table 71. Merck KgaA Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 72. Merck KgaA Recent Development Table 73. GlaxoSmithKline Company Detail Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline 3D Printing Drug Formulation and Administration Product Table 76. GlaxoSmithKline Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 77. GlaxoSmithKline Recent Development Table 78. Pfizer Company Detail Table 79. Pfizer Business Overview Table 80. Pfizer 3D Printing Drug Formulation and Administration Product Table 81. Pfizer Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 82. Pfizer Recent Development Table 83. Craft Health Company Detail Table 84. Craft Health Business Overview Table 85. Craft Health 3D Printing Drug Formulation and Administration Product Table 86. Craft Health Revenue in 3D Printing Drug Formulation and Administration Business (2018-2023) & (US$ Million) Table 87. Craft Health Recent Development Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global 3D Printing Drug Formulation and Administration Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global 3D Printing Drug Formulation and Administration Market Share by Type: 2022 VS 2029 Figure 3. MED Features Figure 4. FDM Features Figure 5. SSE Features Figure 6. Other Features Figure 7. Global 3D Printing Drug Formulation and Administration Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global 3D Printing Drug Formulation and Administration Market Share by Application: 2022 VS 2029 Figure 9. Drugs Case Studies Figure 10. Dietary Supplement Case Studies Figure 11. 3D Printing Drug Formulation and Administration Report Years Considered Figure 12. Global 3D Printing Drug Formulation and Administration Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 13. Global 3D Printing Drug Formulation and Administration Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 14. Global 3D Printing Drug Formulation and Administration Market Share by Region: 2022 VS 2029 Figure 15. Global 3D Printing Drug Formulation and Administration Market Share by Players in 2022 Figure 16. Global Top 3D Printing Drug Formulation and Administration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Drug Formulation and Administration as of 2022) Figure 17. The Top 10 and 5 Players Market Share by 3D Printing Drug Formulation and Administration Revenue in 2022 Figure 18. North America 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 19. North America 3D Printing Drug Formulation and Administration Market Share by Country (2018-2029) Figure 20. United States 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Canada 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe 3D Printing Drug Formulation and Administration Market Share by Country (2018-2029) Figure 24. Germany 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. France 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. U.K. 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Italy 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Russia 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Nordic Countries 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific 3D Printing Drug Formulation and Administration Market Share by Region (2018-2029) Figure 32. China 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Japan 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. South Korea 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Southeast Asia 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. India 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Australia 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America 3D Printing Drug Formulation and Administration Market Share by Country (2018-2029) Figure 40. Mexico 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Brazil 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa 3D Printing Drug Formulation and Administration Market Share by Country (2018-2029) Figure 44. Turkey 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Saudi Arabia 3D Printing Drug Formulation and Administration Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Aprecia Pharmaceuticals Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 47. Triastek Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 48. FabRx Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 49. Multiply Labs Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 50. Merck KgaA Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 51. GlaxoSmithKline Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 52. Pfizer Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 53. Craft Health Revenue Growth Rate in 3D Printing Drug Formulation and Administration Business (2018-2023) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed
Aprecia Pharmaceuticals Triastek FabRx Multiply Labs Merck KgaA GlaxoSmithKline Pfizer Craft Health
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients